Regeneration of endogenous myocardial tissue by induction of neovascularization

Details for Australian Patent Application No. 2003231090 (hide)

Owner The Trustees of Columbia University in the City of New York

Inventors Itescu, Silviu

Agent FB Rice

Pub. Number AU-B-2003231090

PCT Number PCT/US03/12768

PCT Pub. Number WO2003/090512

Priority 10/128,738 23.04.02 US

Filing date 23 April 2003

Wipo publication date 10 November 2003

Acceptance publication date 1 October 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/045 (2006.01) - Hydroxy compounds, e.g. alcohols

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 35/32 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Bones

A61K 35/36 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Skin

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 10/128,738 23.04.02 US

18 December 2003 Application Open to Public Inspection

  Published as AU-B-2003231090

1 October 2009 Application Accepted

  Published as AU-B-2003231090

28 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003231091-APPARATUS AND METHODS FOR REDUCTION OF COHERENT NOISE IN A DIGITAL SIGNAL AVERAGER

2003231089-A DNA enzyme to inhibit plasminogen activator inhibitor-1